Sana Biotechnology, Inc. (NASDAQ:SANA) Receives $10.80 Consensus Price Target from Brokerages
Shares of Sana Biotechnology, Inc. (NASDAQ:SANA – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven research firms that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average […]
Shares of Sana Biotechnology, Inc. (NASDAQ:SANA – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven research firms that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average […]
